[
    [
        {
            "time": "",
            "original_text": "王老吉药业股权纠纷终落定，成为白云山控股子公司",
            "features": {
                "keywords": [
                    "王老吉",
                    "药业",
                    "股权纠纷",
                    "落定",
                    "白云山",
                    "控股子公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "王老吉药业股权纠纷终落定，成为白云山控股子公司",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]